| 11198872 |
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof |
William Querbes, Kevin Fitzgerald, James Butler, Stephanie Williams, Martin Maier |
2021-12-14 |
| 11180757 |
17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof |
Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng +6 more |
2021-11-23 |
| 11149273 |
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene |
Antonin de Fougerolles, Tatiana Novobrantseva |
2021-10-19 |
| 11142766 |
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof |
Kevin Fitzgerald, William Querbes, James Butler, Stephanie Williams, Abigail Liebow +4 more |
2021-10-12 |
| 11136582 |
Ketohexokinase (KHK) iRNA compositions and methods of use thereof |
Kevin Fitzgerald, Brian Bettencourt, Jennifer Willoughby |
2021-10-05 |
| 11091761 |
Organic compositions to treat HSF1-related diseases |
Satyanarayana Kuchimanchi, Stuart Milstein, Markus Warmuth, Wenlai Zhou, Ping Zhu +1 more |
2021-08-17 |
| 11066670 |
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereof |
James Butler, Kevin Fitzgerald, Brian Bettencourt, Huilei Xu |
2021-07-20 |
| 11060091 |
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof |
Laura Sepp-Lorenzino, Vasant Jadhav, Martin Maier, Stuart Milstein, Muthiah Manoharan +1 more |
2021-07-13 |
| 11052103 |
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof |
Kevin Fitzgerald |
2021-07-06 |
| 11034958 |
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof |
Kevin Fitzgerald, William Querbes, James Butler, Stephanie Williams, Abigail Liebow +4 more |
2021-06-15 |
| 11015201 |
Angiotensinogen (AGT) iRNA compositions and methods of use thereof |
Donald C. Foster, Mark K. Schlegel |
2021-05-25 |
| 10982215 |
Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof |
— |
2021-04-20 |
| 10968452 |
Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof |
— |
2021-04-06 |
| 10954516 |
GNAQ targeted dsRNA compositions and methods for inhibiting expression |
Jared Gollob, Ivanka Toudjarska, David Bumcrot |
2021-03-23 |
| 10946107 |
Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof |
— |
2021-03-16 |
| 10934544 |
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof |
Akin Akinc, Martin Maier, James Butler, Jingxuan Liu |
2021-03-02 |
| 10920223 |
Serpina1 iRNA compositions and methods of use thereof |
Alfica Sehgal, Klaus Charisse, Brian Bettencourt, Martin Maier, Kallanthottathil G. Rajeev +1 more |
2021-02-16 |
| 10889813 |
Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof |
— |
2021-01-12 |
| 10883107 |
Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof |
— |
2021-01-05 |